The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Construction litigation for a general contractor
Represented the general contractor in disputes surrounding the construction of a 70,000 square foot casino. During construction, our more
Counsel on construction of the 5th Runway at Hartsfield-Jackson Atlanta International Airport for the City of Atlanta
The firm served as lead counsel to the City of Atlanta on the construction of a 5th 9,000 foot runway at Hartsfield-Jackson Atlanta more
ERISA class action involving Reynolds American Inc.

Represented R.J. Reynolds Tobacco Company (RJRT) successfully in Employee Retirement Security Act (“ERISA”) class action. On February 18, 2016, more

In re Friedman’s, Inc.
Representation of Friedman's Inc. and Crescent Jewelers Inc., a leading U.S. operator of jewelry stores, as lead debtors' counsel in more